Pfizer’s latest share move reflects renewed attention on its label expansion, research pipeline, dividend profile, and long-term growth debate.
PFE is betting on monthly obesity treatments and new oral programs to challenge LLY and NVO in a market projected to hit $120 billion by 2035.
Hosted on MSN
Pfizer share price rises 13% post Q4 Results, dividend announcement despite stock Market crash: Do you own?
Stock Market Today: Pfizer share price gained 13% in the intraday trades on Tuesday. This rise in the Pfizer share price was post Q4 Results, dividend announcement of RS 135 a share and despite stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results